Does IAVI have any special strategy for India, considering the current high HIV-1 disease burden?
During the last 5 years, IAVI has received tremendous support and encouragement from the Presidents, Prime-Ministers and members of Parliament of India. IAVI has established a regional office in New Delhi and helped build clinical infrastructure in collaboration with premier Institutes of the ICMR and successfully initiated clinical trials at the National AIDS Vaccine research (NARI-Pune) and Tuberculosis Research Center (TRC-Chennai). Additionally, several programs have been undertaken to educate religious leaders, members of parliament, NGOs and the community on the disease, literacy and prevention. IAVI is currently engaging premier scientific institutions within India on several research programs to design immunogens for eliciting neutralizing antibodies to the HIV virus. Additional investigations on sequencing several isolates from India are also planned.
